[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100521828":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":41,"responsibleParty":60,"collaborators":62,"id":66,"slug":25,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":25,"eligibilityCriteria":70,"healthyVolunteers":67,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":25,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":25,"overallStatus":43,"whyStopped":25,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Roswell Park Cancer Institute","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CareMeds Intervention","EXPERIMENTAL","Participants complete the CareMeds parent training sessions during weeks 2, 3 and 4.",[13],"Behavioral: CareMeds Intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care","ACTIVE_COMPARATOR","Usual care consists of medical consultations and supportive care, The usual care group will serve as a delayed intervention\u002Fwait list group for which 3 parent training sessions will be offered during weeks 13 through 15.",[19],"Behavioral: Usual Care Group",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","3 parenting sessions will be offered during weeks 2 through 4 of the study period.",[9],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Usual Care Group","3 parenting sessions will be offered during weeks 13 through 15 of the study period.",[15],[31],{"name":32,"affiliation":33,"role":34},"Elizabeth Bouchard, PhD","Roswell Park Comprehensive Cancer Center","PRINCIPAL_INVESTIGATOR",[36],{"name":32,"role":37,"phone":38,"phoneExt":39,"email":40},"CONTACT","716-845-1300","8357","Elizabeth.Bouchard@roswellpark.rog",[42],{"facility":33,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"RECRUITING","Buffalo","New York","14263","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-78.87837,42.88645,{"lat":53,"lon":52},[56],{"name":57,"role":37,"phone":58,"phoneExt":25,"email":59},"Elizabeth Bouchard, MD","716-845-8357","elizabeth.Bouchard@roswellpark.org",{"type":61,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[63],{"name":64,"class":65},"National Cancer Institute (NCI)","NIH","100521828",false,"NCT06074666","Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3","Inclusion Criteria:\n\n* Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.\n* Parent has primary medication responsibility.\n* Pediatric patient aged 3-9 years\n* Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP.\n* Parent has verbal English or Spanish fluency.\n* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee\u002FInstitutional Review Board approved written informed consent form prior to receiving any study related procedure\n\nExclusion Criteria:\n\n* Parent is unwilling or unable to follow protocol requirements","ALL","3 Years","9 Years",{"count":75,"type":76},100,"ESTIMATED","INTERVENTIONAL",[79],"NA","The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.",[82],"Acute Lymphoblastic Leukemia, Pediatric","2026-04-22",{"date":85,"type":86},"2026-04-23","ACTUAL",{"date":88,"type":86},"2024-11-07",{"date":90,"type":76},"2027-10-01",{"name":5,"class":6},1]